Promomed launched Russia's first subscription program for patients receiving course drugs. It allows patients to purchase drugs at significant discounts and adhere to the prescribed therapy without interruptions in a comfortable financial mode. At the first stage, the subscription is available for four drugs: Quinsenta®, Velgia®, Enligria® and Tirsetta®.